DNA test provider Prenetics jumps after lifting annual forecast
** Shares of DNA test provider Prenetics Global PRE.O rise 16.25% at $10.30 in early trading ** Co increases FY2025 revenue outlook to $85 mln to $100 mln from previous forecast of $80 mln to $100 mln; aims for break-even in Q1 2026 ** Prenetics reports almost 600% quarterly revenue jump of $17.7 million compared to previous year, but below expectations of $21.70 million - data compiled by LSEG ** As of last close, PRE up 52.76% YTD (Reporting by Anuj T in Bengaluru) ((Anuj.T@thomsonreuters.com))
Recent news on Prenetics Global
See all newsBrief: Prenetics’ Im8 Announces Two-Time Golden Globe-Nominated Actress And Producer Lily Collins As Im8 Global Ambassador And Shareholder In Multi-Year Partnership
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
Prenetics Global Ltd reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics